These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4381869)

  • 1. The effects of barbiturates on the activity of the catecholamine neurones in the rat brain.
    Corrodi H; Fuxe K; Hökfelt T
    J Pharm Pharmacol; 1966 Aug; 18(8):556-8. PubMed ID: 4381869
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of ethanol on the activity of central catecholamine neurones in rat brain.
    Corrodi H; Fuxe K; Hökfelt T
    J Pharm Pharmacol; 1966 Dec; 18(12):821-3. PubMed ID: 4381667
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of neuroleptics on the activity of central catecholamine neurones.
    Corrodi H; Fuxe K; Hökfelt T
    Life Sci; 1967 Apr; 6(7):767-74. PubMed ID: 6031261
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
    Corrodi H; Fuxe K
    Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of alpha-methyltyrosine and disulfiram on inhibitory function of the caudate nucleus and the catecholamine concentration in the cat brain.
    Arushanyan EB; Stolyarov GV; Tolpyshev BA
    Bull Exp Biol Med; 1974 Aug; 77(2):139-42. PubMed ID: 4433917
    [No Abstract]   [Full Text] [Related]  

  • 6. Stress-related effects of various inhibitors of catecholamine synthesis in the mouse.
    Thornburg JE; Moore KE
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):158-67. PubMed ID: 4399378
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of reserpine, alpha-methyl-m-tyrosine, prenylamine, and guanethidine on metrazol-convulsions and the brain monoamine level in mice.
    Pfeifer AK; Galambos E
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):201-11. PubMed ID: 6030237
    [No Abstract]   [Full Text] [Related]  

  • 8. Difference in oral effectiveness of two tyrosine hydroxylase inhibitors.
    Johnson GA; Kim EG; Veldkamp W; Russell R
    Biochem Pharmacol; 1967 Feb; 16(2):401-3. PubMed ID: 6029921
    [No Abstract]   [Full Text] [Related]  

  • 9. On the use of the fluorescence histochemical method to estimate catecholamine content in brain.
    Bacopoulos NG; Bhatnagar RK; Schnute WJ; Van Orden LS
    Neuropharmacology; 1975 Apr; 14(4):291-9. PubMed ID: 1128763
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of -methyl-meta-tyrosine on spontaneous and caudate-induced electroencephalogram activity and regional catecholamines in the cat brain.
    Shellenberger MK
    J Pharmacol Exp Ther; 1971 Jun; 177(3):481-90. PubMed ID: 5568803
    [No Abstract]   [Full Text] [Related]  

  • 11. Antagonism by monoamine oxidase inhibitors of alpha-methyltyrosine-induced catecholamine depletion and behavioral depression.
    Moore KE; Rech RH
    J Pharmacol Exp Ther; 1967 Apr; 156(1):70-5. PubMed ID: 6023602
    [No Abstract]   [Full Text] [Related]  

  • 12. The development of monoamine-containing neurones in the brain of the albino rat.
    Loizou LA
    J Anat; 1969 May; 104(Pt 3):588. PubMed ID: 5804578
    [No Abstract]   [Full Text] [Related]  

  • 13. Regional role of catecholamines in alpha methyl-m-tyrosine- induced electroencephalographic arousal.
    Shellenberger MK; Gordon JH
    Exp Neurol; 1975 Nov; 49(2):370-85. PubMed ID: 1193194
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.
    Breese GR; Traylor TD
    J Pharmacol Exp Ther; 1970 Sep; 174(3):413-20. PubMed ID: 5456173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of a possible interference of alpha-methyl-para-tyrosine pretreatment on the radioenzymatic assay of catecholamines in the rat brain.
    Tizabi Y; Massari VJ; Jacobovitz DM
    J Neurochem; 1979 Oct; 33(4):959-61. PubMed ID: 385810
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of inhibition of catecholamine synthesis on central catecholamine-containing neurones in the developing albino rat.
    Loizou LA
    Br J Pharmacol; 1971 Jan; 41(1):41-8. PubMed ID: 5547761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of morphine intoxication on brain catecholamine neurons.
    Gunne LM; Jonsson J; Fuxe K
    Eur J Pharmacol; 1969 Mar; 5(4):338-42. PubMed ID: 4306742
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of alpha-methyltyrosine on operant behavior and brain catecholamine levels.
    Schoenfeld RI; Seiden LS
    J Pharmacol Exp Ther; 1969 Jun; 167(2):319-27. PubMed ID: 5787869
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioral and catecholamine depleting effects of alpha-methyl-5-hydroxytryptophan.
    Dominic JA; Moore KE
    Eur J Pharmacol; 1969 Dec; 8(3):292-5. PubMed ID: 5308817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.